New Humana Healthcare Research Study Finds Favorable Selection in Medicare Advantage is Substantially Lower Than MedPAC Estimates
Humana Healthcare Research published a study in Health Affairs Scholar indicating that favorable selection in Medicare Advantage is substantially lower than estimates by the Medicare Payment Advisory Commission (MedPAC). The study finds favorable selection rates were 4.9%-5.8% from 2020-2022, which is 42%-65% lower than the 10%-15% range often cited in policy discussions.
Key figures
- Estimate reduction vs medpac
- 42%-65%
- Favorable selection hhr estimate
- 4.9%-5.8%
- Favorable selection medpac estimate
- 10%-15%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.